PhosphoSolutions

894 products

PhosphoSolutions’ Antibodies that Work™ have been made and tested in Denver, Colorado since 2001. With a focus in both neuroscience and cancer research, we pride ourselves on offering the highest quality antibodies and customer support in the business. Our serum-pooling initiative ensures reproducible polyclonal antibodies that come with a 100% satisfaction guarantee. Our all-inclusive custom antibody services allow you to work directly with the scientist developing your antibody: from design and immunization to purification and characterization. We understand how frustrating it can be to conduct research using ineffective antibodies, and we believe that you shouldn’t have to.

Showing 337 - 360 of 894 products

PhosphoSolutions Anti-RSV Antibody

$445

PhosphoSolutions Anti-BRSV Antibody

$445

PhosphoSolutions Anti-RSV RSS-2 Antibody

$445

PhosphoSolutions Anti-Hepatitis E Virus Antibody

$445

PhosphoSolutions Anti-Hepatitis G Virus Antibody

$445

Western blot analysis of WWP1 expression in adult mouse liver (lane 1) and human prostate adenocarcinoma (PC3) cells (lane 2). The blot was probed with anti-WWP1 (WP3931) at 1:1000.

PhosphoSolutions Anti-WWP1 (N-terminus) Antibody

$285

Western blot of human K562 cells treated with pervanadate (1 mM, 30 min) (lanes 1 & 3) then treated with alkaline phosphatase (lanes 2 & 4). The blots were probed with anti-WAVE2 (Central region) (lanes 1 & 2) or anti-WAVE (Tyr-150) (lanes 3 & 4).

PhosphoSolutions Anti-WAVE2 (Tyr-150) [conserved site], Phosphospecific Antibody

$340

Western blot of rat PC12 lysate. The blots were probed with anti-WAVE2 (Central region) in the presence (lane 2) or absence (lane 1) of WAVE2 (Central region) blocking peptide.

Immunocytochemical labeling of WAVE2 in rat PC12 cells differentiated with NGF. The cells were labeled with rabbit polyclonal WAVE2 (Central) antibody, then detected using appropriate secondary antibody conjugated to Cy3. The antibody was used in the absence (left) or presence (right) of blocking peptide (WX1795).

PhosphoSolutions Anti-WAVE2 (Central region) Antibody

$340

Western blot of human SYF cSrc transformed cells untreated (lanes 1 & 3) or treated (lanes 2 & 4) with pervanadate (1 mM; 30 min). The blots were probed with anti-WAVE1 (N-terminal region) (lanes 1 & 2) or anti-WAVE (Tyr-125) (lanes 3 & 4).

Immunocytochemical labeling of phosphorylated WAVE in pervanadate-treated mouse C2C12. The cells were labeled with rabbit polyclonal WAVE1 (N-terminal region) and WAVE (Tyr-125) antibodies, then the antibodies were detected using appropriate secondary antibodies conjugated to Cy3.

PhosphoSolutions Anti-WAVE1 (Tyr-125), Phosphospecific Antibody

$340

Western blot of control and alkaline phosphatase-treated (AP) neonatal rat brain lysate (20 µg/lane). Blots were probed with anti-N-WASP (Lanes 1 & 2), anti-phospho-N-WASP (S484/S485) (Lanes 3 & 4), or anti-unphosphorylated-N-WASP (S484/S485) (Lanes 5 & 6).

Immunocytochemical labeling of phospho- and unphospho-N-WASP in rabbit spleen fibroblasts. The cells were probed with N-WASP (Ser-484/Ser-485) phospho-specific and N-WASP (Ser-484/Ser-485) unphosphorylated antibodies, then the antibodies were detected using appropriate secondary antibodies conjugated to Cy3. The antibodies were used in the absence (left) or presence (right) of blocking peptide (WX2205 or WX2405).

PhosphoSolutions Anti-N-WASP Antibody

$340

Western blot analysis of control and alkaline phosphatase-treated (AP) neonatal rat brain lysate (20 µg/lane). Blots were probed with anti-N-WASP (Lanes 1 & 2), anti-phospho-N-WASP (S484/S485) (Lanes 3 & 4), or anti-unphosphorylated-N-WASP (S484/S485) (Lanes 5 & 6).

Immunocytochemical labeling of phosphorylated and unphosphorylated N-WASP in rabbit spleen fibroblasts. The cells were probed with N-WASP (Ser-484/Ser-485) phospho-specific and N-WASP (Ser-484/Ser-485) unphosphorylated antibodies, then the antibodies were detected using appropriate secondary antibodies conjugated to Cy3. The antibodies were used in the absence (left) or presence (right) of their respective blocking peptide (WX2205 or WX2405).

PhosphoSolutions Anti-N-WASP (Ser-484/Ser-485), Phosphospecific Antibody

$340

Western blot analysis of control and pervanadate-treated A431 cells (20 µg/lane). Blots were probed with either rabbit polyclonal anti-N-WASP (Ser-484/Ser-485) or anti-N-WASP (Tyr-256).

Immunocytochemical labeling of N-WASP in control and pervanadate-treated A431 cells. The cells were labeled with rabbit polyclonal N-WASP/WASP (WP2101) or rabbit polyclonal N-WASP (Tyr-256) antibodies, then the antibodies were detected using appropriate secondary antibody conjugated to DyLight® 594.

PhosphoSolutions Anti-N-WASP (Tyr-256), Phosphospecific Antibody

$340

PhosphoSolutions Anti-N-WASP Antibody

$340

Western blot analysis of Jurkat (lane 1), A431 (lane 2), and HeLa (lane 3) cell lysates (20 µg/lane). Blots were probed with rabbit polyclonal anti-WASP/N-WASP (WP2101).

PhosphoSolutions Anti-WASP / N-WASP Antibody

$340

Immunocytochemical labeling of Vimentin in paraformaldehyde fixed and NP-40 permeabilized A7r5 cells. The cells were labeled with a mouse monoclonal antibody to Vimentin (VM4341), then the antibody was detected using Goat anti-Mouse secondary antibody conjugated to DyLight® 594.

Western blot image of cell structure markers in NCI-H1915 lung carcinoma cells. The blot was probed with anti-Vimentin intermediate
filament protein VM4341 (lane 1), anti-Nucleoporin p62 NM4361 (lane 2), anti-Hsp60 mitochondrial protein HM4381 (lane 3), and anti-Calnexin endoplasmic reticulum protein CM4371 (lane 4).

PhosphoSolutions Anti-Vimentin Antibody

$285

Left: Western blot image of human K-562 cells (lanes 1 & 2) and HUVEC (lanes 3 & 4). The blots were probed with rabbit polyclonal anti-VEGFR-3 (a.a. 1285-1298) in the absence (lanes 1 & 3) or presence of blocking peptide (VX2945) (lanes 2 & 4). Right: Western blot image of GST-recombinant human VEGFR-1 (89 kDa), VEGFR-2 (110 kDa), and VEGFR-3 (86 kDa) C-terminal regions. The blot was probed with anti-VEGFR-3 (a.a. 1285-1298).

PhosphoSolutions Anti-VEGFR-3 (N-terminus) Antibody

$285

Western blot image of GST-recombinant human VEGFR-1 (89 kDa), VEGFR-2 (110 kDa), and VEGFR-3 (86 kDa) C-terminal regions. The blots were probed with rabbit polyclonal anti-VEGFR-2 (a.a. 1304-1317), anti-VEGFR-2 (Tyr-801, conserved site), and anti-VEGFR-3 (a.a. 1285-1298).

Left: Western blot image of HUVEC cells untreated (-) or treated with pervanadate (1 mM) for 30 min. (+). Right: Western blot image of GST-recombinant VEGFR-2 kinase without (-) or with (+) akaline phosphatase treatment. Both sets of blots were probed with rabbit polyclonal anti-VEGFR-2 (a.a. 1304-1317) or anti-VEGFR-2 (Tyr-801).

PhosphoSolutions Anti-VEGFR-2 (Tyr-801) [conserved site], Phosphospecific Antibody

$340

PhosphoSolutions Anti-VEGFR-2 Antibody

$285

Western blot of human Jurkat (lanes 1 & 4), HUVEC (lanes 2 & 5), and A431 (lanes 3 & 6) cells. The blots were probed with anti-Vav2 (a.a. 309-322) at a dilution of 1:500 (lanes 1-3) and anti-Vav3 (a.a. 293-305) at 1:500 (lanes 4-6).

PhosphoSolutions Anti-Vav3 Antibody

$285

PhosphoSolutions Anti-Vav2 Antibody

$285

Western blot of human A431 cells treated with EGF (lanes 1, 3, & 5) then the blot was exposed to alkaline phosphatase (lanes 2, 4, & 6). The blots were probed with anti-Vav (a.a. 165-174) (lanes 1 & 2), anti-Vav2 (Tyr-142) (lanes 3 & 4), or anti-Vav2 (Tyr-172) (lanes 5 & 6).

Immunocytochemical labeling of VAV2 in control and pervanadate-treated human A431 cells. The cells were fixed in paraformaldehyde and permeabilized using NP-40. Then labeled with rabbit polyclonal Vav2 (Tyr-172). The antibody was detected using goat anti-rabbit DyLight® 594.

PhosphoSolutions Anti-Vav2 (Tyr-172) [conserved site], Phosphospecific Antibody

$340

PhosphoSolutions Anti-Vav2 (Tyr-142) [conserved site], Phosphospecific Antibody

$340

Immunocytochemical labeling of Vav in paraformaldehyde-fixed and NP-40-permeabilized rabbit spleen fibroblasts. The cells were labeled with rabbit polyclonal Vav (a.a. 165-174), and detected using appropriate secondary antibody conjugated to Cy3.

PhosphoSolutions Anti-Vav2 Antibody

$285

Western blot image of human A431 cells stimulated with calyculin A (100 nM) for 30 min. The blots were untreated (lanes 1 & 3) or treated with lambda phosphatase (lanes 2 & 4), then probed with mouse monoclonal VASP (C-term.) antibody (lanes 1 & 2) or rabbit polyclonal VASP (Thr-278) phospho-specific antibody (lanes 3 & 4).

Immunocytochemical labeling of VASP phosphorylation in rabbit spleen fibroblasts treated with Calyculin A. The cells were labeled with rabbit polyclonal VASP (Thr-278) antibody, then detected using appropriate secondary antibodies conjugated to Cy3. The antibody was used in the absence (top left) or presence (top right) of blocking peptide (VX2785). Corresponding phase images are shown bottom left and right.

PhosphoSolutions Anti-VASP (Thr-278), Phosphospecific Antibody

$340

Previous Page 15 / 38Next

Recover password

Create my account

PhosphoSolutions

Recently Viewed